World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 22 February 2013
Main ID:  ACTRN12608000492358
Date of registration: 30/09/2008
Primary sponsor: Individual School of Psychiatry, University of New South Wales. Doctorate supervsior Professor Philip Mitchell MB BS (Syd), MD (UNSW), FRANZCP, FRCPsych
Public title: 'Taking control of Bipolar Disorder: staying well, learning more': a 12 month Randomised controlled trial evaluating an online relapse prevention program for bipolar disorder Web study for bipolar disorder
Scientific title: Randomised controlled trial of an online adjunctive program for people with bipolar disorder to see if effective in reducing rates of relapse during phase I , 12 month exposure to the study and phase II during 12 month follow up period.
Date of first enrolment: 1/07/2006
Target sample size: 240
Recruitment status: Closed: follow-up continuing
URL:  http://www.anzctr.org.au/ACTRN12608000492358.aspx
Study type:  Interventional
Study design:  Randomised controlled trial  Other
Countries of recruitment
Australia
Contacts
Name:   Dr Caryl Barnes
Address:  c/o Professor Philip Mitchell School of Psychiatry University of New South Wales Black Dog Institute Buliding Hospital Road Randwick Sydney 2031, Australia
Telephone: +61-2-93823711
Email: c.barnes@unsw.edu.au
Affiliation: 
Name:   Dr Caryl Barnes
Address:  c/o Professor Philip Mitchell School of Psychiatry University of New South Wales Black Dog Institute Buliding Hospital Road Randwick Sydney 2031, Australia
Telephone: +61-2-93823711
Email: c.barnes@unsw.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria
Over 18 years of age
Meets criteria for bipolar disorder as confirmed by completion of screening questionnaire
To have a diagnosis of bipolar disorder (diagnosis has to have been made by a mental health professional)
Currently under care of psychiatrist or general practitioner
Taking medication for bipolar disorder.
Has access to internet and printer- at home/ work.
Has an email account/ has email address.
Able to understand written English
Interested in using web based program

Exclusion criteria: Exclusion criteria
Under 18 years of age
Diagnosis of bipolar disorder not supported by results of study screening questionnaire
Not currently under the care of a psychiatrist or general practitioner.
Not on medication for bipolar disorder.


Age minimum: 18 Years
Age maximum: 0 No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Bipolar disorder
Intervention(s)
Study program ‘Recovery road for Bipolar Disorder’ is an online program, accessed through a secure server and website that delivers 'sessions' that combine mood monitoring with psycho-educational material around a variety of topics including; signs and symptoms of bipolar disorder, dealing with medication and managing medication side effects, psychological issues and dealing with relationships and Staying safe. It includes 10 sessions of Cognitive behavioural therapy that focuses on learning to recognise early warning signs of relapse and using these approaches to stay well. A battery of online questionnaires is completed at the start of each session by both study and control parctipant and this makes up the ‘mood monitoring’ section of the programs (includes Beck Depression Inventory, Internal State Scale and Sheehan Disability scales). Only participants in the study program ‘Recovery Road’ receive feedback on their scores and progress, however, from these surveys. Each session is scheduled at fixed intervals over the 12 month study period with a 'window' of 5 days for a participant to access that session. This is the 'session duration' however after this cloases although they can no longer access the mood monitoring/survey section partcipants can still access the content for each current and past sessions through out the 12 month period. Email reminders will be sent during this time to reminding participants to go online, if at the end of the 5 day 'window' this hasn't occurred , a phone call reminder will be made by a research officer to that parctipant. After this time the mood monitoring section is closed. New sessions are scheduled weekly for the first 8 weeks, then fortnightly for a further 4 weeks and then monthly for the remainder of the study period which is in total 12 months. Study participants can track mood swings via feedback from some scales both in report form and graphically. Other features include ability to keep and online journal, an online personal medical record and an 'Appointment Diary' which records contact with mental health services. At the end of the 12 month period participants can choose to either finish their involvement in the study or can consent to enrol into Phase II of the study which is a monitoring only program. This will run for a further 12 months. It will involve mood monitoring via the same set of questionnaires but at 3, 6, 9 and 12 month time intervals. Those randomised into the control program, if they complete the full 12 months will be eligible to enrol into study program which will then run for a further 12 months with data taken at same time intervals
Primary Outcome(s)
Impact of both programs on the level of functioning as measured by Sheehan Disability Scale
Survival analysis, from start of program time to relapse as defined by scores on Beck depression Inventory, using cut offs defined in paper version. Survival analysis, time to relapse as defined by mood state discriminator function of the Internal State Scale.

Survival analysis, time to relapse as defined by self report of admission into hospital.
Secondary Outcome(s)
Compliance with medication as seen by entries into the 'Medication diary' section of the program. Comparisons will be possible with side effect burden due to the completion of a General Symptom Scale which records presence and severity of variety of side effects that can occur with frequently used bipolar medications.
Secondary ID(s)
Source(s) of Monetary Support
National Health and Medical Research Concil (NHMRC)
Secondary Sponsor(s)
Kay Wilhelm AM, MB BS, MD, FRANZCP
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history